Zymeworks Inc. (ZYME) stock
ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value
$26.47−2.60 (-8.94%)
Close on Nov 12, 2026Market cap $1.88BP/E 50.9Yield –
Zymeworks total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Zymeworks
Zymeworks has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?